The first Edwards Lifesciences trade was made in Q2 2018. Since then AKO Capital bought shares five more times and sold shares on three occasions. The investor completely sold their stake between Q1 2020 and Q2 2020.
EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / December 3, 2024 / Hagens Berman urges...
SAN FRANCISCO, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...
SAN FRANCISCO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...